The Biostatistics Core (BC) provides expertise in biostatistics, clinical trials, and experimental design, as wellas supporting electronic data management for clinical research. Scientific consultation is provided by facultystatisticians who collaborate in the development of pilot projects, grant proposals and clinical protocols. TheBC statisticians help design research studies, and conduct interim and final data analyses. Core servicesinclude the development of case-report forms, databases and data entry tools to initiate clinical protocols, aswell as access to clinical research and cancer registry data repositories for retrospective research. The Coreprovides expertise and access to a variety of technologies, including modern statistical computingenvironments such as SAS, JMP, Splus, and R; specialized statistical computing tools for microarrays,genetic linkage and association studies, and pharmacokinetics; tools to implement scannable forms andelectronic data capture; web portals for data entry and study monitoring; and a centralized MS SQL-serverdatabase for clinical research. Service to the institution includes statistical review of cancer-related clinicalresearch protocols. The core is directed by Jeffrey Longmate, PhD, Director of the Department ofBiostatistics. Co-Director is Joyce Niland, PhD, Director of the Clinical Protocol Management Core. The staffof the BC includes a large part of the department, and the BC enables their participation in Cancer Centerrelatedpilot projects and proposals, which may later develop into externally funded projects. The BC isdirectly involved in Cancer Center research from the inception of a research idea to the publication of results.The BC focuses heavily on clinical research, but also supports basic and translational research, as well assupporting several other cores. The BC collaborates continually with the Biomedical Informatics Core tooperate and further develop the MIDAS clinical research database, and regularly collaborates with membersof the Clinical Protocol Management Core to implement City of Hope-conducted or coordinated clinicalprotocols. In 2005, the BC was used by 80 CC members from all Programs, and logged 204 projects,including 21 grants naming BC personnel (7 multi-project grants), and 32 clinical protocols newly openedwith BC collaboration. Annual budget for the core is $2,651,640, with 62% from the institution, 34% othersources, and 4% ($100,100) requested from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA033572-25
Application #
7714130
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-01
Project End
2012-11-30
Budget Start
2008-09-01
Budget End
2008-11-30
Support Year
25
Fiscal Year
2008
Total Cost
$71,000
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Salgia, Ravi; Kulkarni, Prakash; Gill, Prakash S (2018) EphB4: A promising target for upper aerodigestive malignancies. Biochim Biophys Acta Rev Cancer 1869:128-137
Choi, Audrey H; O'Leary, Michael P; Lu, Jianming et al. (2018) Endogenous Akt Activity Promotes Virus Entry and Predicts Efficacy of Novel Chimeric Orthopoxvirus in Triple-Negative Breast Cancer. Mol Ther Oncolytics 9:22-29
Kumar, B; Garcia, M; Weng, L et al. (2018) Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion. Leukemia 32:575-587
Zhou, Jiehua; Lazar, Daniel; Li, Haitang et al. (2018) Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1. Theranostics 8:1575-1590
Ding, Yuan Chun; Adamson, Aaron W; Steele, Linda et al. (2018) Discovery of mutations in homologous recombination genes in African-American women with breast cancer. Fam Cancer 17:187-195
Kurata, Jessica S; Lin, Ren-Jang (2018) MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs. RNA 24:966-981
Hardwick, Nicola R; Frankel, Paul; Ruel, Christopher et al. (2018) p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy. Clin Cancer Res 24:1315-1325
Dietze, Eric C; Chavez, Tanya A; Seewaldt, Victoria L (2018) Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology. Am J Pathol 188:280-290
Kingsmore, Kathryn M; Vaccari, Andrea; Abler, Daniel et al. (2018) MRI analysis to map interstitial flow in the brain tumor microenvironment. APL Bioeng 2:
Wang, Sophia S; Carrington, Mary; Berndt, Sonja I et al. (2018) HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes. Cancer Res 78:4086-4096

Showing the most recent 10 out of 1396 publications